235 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (89)
- Autoimmune Disorders (1)
- Blood Disorders (3)
- Bone & Muscle (1)
- Cancer (18)
- COVID-19 (Coronavirus) (4)
- Diabetes (2)
- Endocrine & Metabolic Disease (3)
- Hair and Skin Disorders (1)
- Healthy Volunteers (12)
- Heart Disease (17)
- (-) Kidney Disease (1)
- Liver Disease (2)
- (-) Lung Disease (2)
- Neurological Disorders (3)
- Nutrition (2)
- Obesity (2)
- Obstetrics & Gynecology (3)
- Pediatrics (7)
- Surgery (2)
- Transplant (3)
Displaying 1 - 3 of 3
Condition: Lung Disease
Investigator: Emily DiMango, MD
Status: Closed
This research is being done to look at how a medicine called Losartan helps people with Chronic Obstructive Pulmonary Disease (COPD) with emphysema, a disease of the lungs. COPD is often caused by cigarette smoking. It includes the symptoms of emphysema and chronic bronchitis. Although some medications for COPD reduce symptoms and prevent exacerbations, few…
Condition: Kidney Disease
Investigator: Jai Radhakrishnan, MD
Status: Closed
This study is for patients with autosomal dominant polycystic kidney disease (ADPKD). The purpose of this study is to test the effectiveness of a study drug called tolvaptan. Tolvaptan continues to be studied in this trial as a possible treatment for ADPKD. ADPKD is a disease that causes kidney cysts (cyst are like fluid-filled balloons), worsening kidney…
Condition: Lung Disease
Investigator: Keith Brenner, MD
Status: Closed
The objective of the Block-COPD Study is to determine if beta-blockers are safe and effective at reducing the number of exacerbations or flare-ups that people living with Chronic Obstructive Pulmonary Disease (COPD) experience. A beta-blockers is a drug that is taken by mouth and is currently used to treat a wide range of diseases including…